Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22163353 | 1.00 | TLR4 (0.30) | TLR4 | |
| SCHEMBL22163315 | 0.85 | — | — | |
| SCHEMBL22115473 | 0.85 | — | — | |
| SCHEMBL22115466 | 0.77 | ALDH1A1 (0.31) | — | |
| SCHEMBL22115469 | 0.77 | ALDH1A1 (0.31) | — | |
| SCHEMBL22163351 | 0.75 | HSD11B1 (0.32) | — | |
| SCHEMBL22115471 | 0.75 | HSD11B1 (0.32) | — | |
| SCHEMBL15116809 | 0.74 | — | — | |
| SCHEMBL18971821 | 0.74 | EPHX1 (0.33) | — | |
| SCHEMBL13863987 | 0.69 | PTPN1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234206-B2 | Bi- and tricyclic compounds for use as aroma chemicals | BASF SE (DE) | 2025-02-25 | — | — | US | disclosed |
| US-20220064095-A1 | BI- AND TRICYCLIC COMPOUNDS FOR USE AS AROMA CHEMICALS | P2 SCIENCE INC. | 2022-03-03 | — | — | US | disclosed |
| EP-3898564-A1 | BI- AND TRICYCLIC COMPOUNDS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020127305-A1 | BI- AND TRICYCLIC COMPOUNDS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020127305-A1 | BI- AND TRICYCLIC COMPOUNDS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-06-25 | — | — | WO | disclosed |
| EP-3670488-A1 | BI- AND TRICYCLIC KETONES FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-06-24 | — | — | EP | disclosed |
| EP-3670488-A1 | BI- AND TRICYCLIC KETONES FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12234206-B2 | Bi- and tricyclic compounds for use as aroma chemicals | CHRM1, C1S, C1R | TLR4 1822/4885 |
| US-20220064095-A1 | BI- AND TRICYCLIC COMPOUNDS FOR USE AS AROMA CHEMICALS | CHRM1, C1S, C1R | TLR4 1878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.